RxDoctor Payments Data

Joseph Winget, MD

Cardiovascular Disease · South Burlington, VTNPI 1275632267

Payments from drug & device makers

What this record shows

This record is dominated by travel and lodging: $749 of the $982 with a category attached, or 76.3%. Every reported general payment came from a single manufacturer, Medtronic. That places this record below the midpoint for cardiovascular disease clinicians in VT, where the typical reported total is $1,258.

$982in general payments, 2019–2025

Across 6 payments — averaging $163.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$982
$148,232in research payments, 2019–2025

Across 201 payments — averaging $737.48 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Medtronic$124K
  • Biotronik Inc.$24K

What the payments were for

  • Travel & lodging$74976%
  • Food & beverage$23224%

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Medtronic6$982

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$982 in reported general payments places this provider in the 45th percentile of 27 cardiovascular disease providers in Vermont.

See all cardiovascular disease providers in Vermont

Medicare billing

Part B allowed, 2024
$173,427
Medicare patients
1,969
Services billed
3,303

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban343$453,294
XareltoRivaroxaban61$79,735
EntrestoSacubitril/Valsartan51$74,019
Dofetilide80$18,945
JardianceEmpagliflozin17$15,226
Diltiazem 24hr Er (Cd)Diltiazem Hcl176$4,749
Metoprolol Succinate189$3,607
Mexiletine Hcl13$2,884
Flecainide Acetate69$2,418
Atorvastatin Calcium128$1,801
Amiodarone Hcl46$1,464
Tiadylt ErDiltiazem Hcl15$911
SotalolSotalol Hcl34$787
Diltiazem 24hr ErDiltiazem Hcl31$785
Metoprolol Tartrate96$768

Paid to pharmacies, not to this prescriber.

Other cardiovascular disease in South Burlington

See the full list for Vermont

Where these figures come from

Is this you, or does something look wrong? →